Structure-based design of imidazo[1,2-a]pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells
✍ Scribed by Nathalie Bouloc; Jonathan M. Large; Magda Kosmopoulou; Chongbo Sun; Amir Faisal; Mizio Matteucci; Jóhannes Reynisson; Nathan Brown; Butrus Atrash; Julian Blagg; Edward McDonald; Spiros Linardopoulos; Richard Bayliss; Vassilios Bavetsias
- Book ID
- 104004813
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 879 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
Co-crystallisation of the imidazo[1,2-a]pyrazine derivative 15 (3-chloro-N-(4-morpholinophenyl)-6-(pyridin-3-yl)imidazo[1,2-a]pyrazin-8-amine) with Aurora-A provided an insight into the interactions of this class of compound with Aurora kinases. This led to the design and synthesis of potent Aurora-A inhibitors demonstrating up to 70-fold selectivity in cell-based Aurora kinase pharmacodynamic biomarker assays.
📜 SIMILAR VOLUMES